INSTRUCTIONS Evaluation and current treatments for urinary incontinence
- Read the article. The test for this CE activity is to be taken online at www.nursingcenter.com/CE/NP. Tests can no longer be mailed or faxed.
- You'll need to create (it's free!) and log in to your personal CE Planner account before taking online tests. Your planner will keep track of all your Lippincott Professional Development online CE activities for you.
- There's only one correct answer for each question. A passing score for this test is 13 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost.
- For questions, contact Lippincott Professional Development: 1-800-787-8985.
- Registration deadline is June 4, 2021.
Lippincott Professional Development will award 1.5 contact hours for this continuing nursing education activity.
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida, CE Broker #50-1223. Your certificate is valid in all states.
Payment: The registration fee for this test is $17.95.
Evaluation and current treatments for urinary incontinence
General Purpose: To review the types of UI, screening measures NPs can employ to identify it early, and various treatment options to help patients with this condition achieve a better quality of life. Learning Objectives/Outcomes: After completing this continuing-education activity, you should be able to: 1. Outline the various factors to consider when assessing patients for UI. 2. Plan the appropriate interventions and treatment options for patients who have UI.
- A common risk factor for developing UI in women is
- Black race.
- Which of the following subtypes of UI occurs without the patient's awareness?
- Which of the following foods can cause bladder irritation and urinary urgency?
- A recent Cochrane review indicated an improvement in quality of life with a decrease in fluid intake, but some of those who reduced fluids reported
- joint pain.
- muscle aches.
- A recommended urge suppression technique is
- counting slowly from 1 to 10.
- removing abdomen-constricting clothing.
- performing “quick flicks” of the pelvic muscles.
- Constipation can contribute to UI because it
- distends the rectum.
- weakens pelvic musculature.
- reduces fluid absorption from the intestines.
- One chronic medical condition that can contribute to unexpected urine leakage is
- coronary artery disease.
- Urethral diverticula cause a classic triad of symptoms: dysuria, dyspareunia, and
- stress incontinence.
- urinary frequency.
- postvoid dribbling.
- Assessing for a descent of the bladder, uterus, or vaginal wall involves having the patient
- perform a Valsalva maneuver.
- perform Kegel exercises.
- In male patients, a digital rectal exam helps assess for prostate size and
- a hypermobile urethra
- penile discharge.
- sphincter tone.
- In a recent Cochrane review, which of the following interventions improved or cured all types of UI in women?
- pelvic floor muscle therapy
- the use of pessaries
- Which of the following types of medication can cause urinary retention or incomplete bladder emptying, ultimately leading to UI?
- selective serotonin reuptake inhibitors
- calcium channel blockers
- cholinesterase inhibitors
- Which of the following drugs treats urgency UI?
- Which of the following is a contraindication for PTNS
- having a pacemaker
- urinary retention
- diathermy use
- A possible adverse reaction to PTNS is
- toe numbness.
- In addition to the spinal nerves of bladder and the urinary sphincter, the implantable neurostimulator device for SNS sends electric stimulation to the spinal nerves of the
- abdominal muscles.
- A contraindication for SNS is
- urinary retention.
- mechanical outlet obstruction.
- Before treatment with intravesical onabotulinumtoxinA, it is important for patients to learn how to perform
- intermittent catherization.
- self-injection techniques.
- Kegel exercises.